(a) optimise the impact of existing interventions, services and commodities aimed at preventing and fighting the major communicable diseases affecting the poorest populations;
(b) increase the affordability of key pharmaceuticals and diagnostics for the three diseases;
(c) increase research and development, including vaccines, microbicides and innovative treatments.